Phaarmasia

Phaarmasia06 May 2024

Pharmaceuticals

₹

-0.20 (-0.48%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Phaarmasia

Phaarmasia

Pharmaceuticals

Phaarmasia06 May 2024

₹

-0.20 (-0.48%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Feb-2024	BC	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obli	13-Feb-2024
07-Nov-2023	BC	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve Prior intimation of Board Meeting to be held on	14-Nov-2023
07-Aug-2023	BC	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. To consider approve and take on record the u	14-Aug-2023
13-Jun-2023	BC	The Board meeting of M/s. Phaarmasia Limited held on Tuesday, the 13th June2023 at 1.00P.M. and ended at 2.00P.M. through video conferencing the following were considered and approved by the Board. 1	10-Jul-2023
10-Jun-2023	BC	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2023 inter alia to consider and approve With reference to the subject cited this is to	13-Jun-2023

No Rights has been declared by Phaarmasia

Book Closure

Record Date	Split Date	Purpose
13-Feb-2024	-	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obli
14-Nov-2023	-	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve Prior intimation of Board Meeting to be held on
14-Aug-2023	-	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. To consider approve and take on record the u
10-Jul-2023	-	The Board meeting of M/s. Phaarmasia Limited held on Tuesday, the 13th June2023 at 1.00P.M. and ended at 2.00P.M. through video conferencing the following were considered and approved by the Board. 1
13-Jun-2023	-	PHAARMASIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2023 inter alia to consider and approve With reference to the subject cited this is to

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Phaarmasia Ltd ₹41.60(-0.20/-0.48%)	41.60	-0.20	28.55	57.68	0.00	4.65
Astrazeneca Pharma India Ltd ₹5,433.65(+9.20/0.17%)	5,433.65	+9.20	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹113.55(-5.55/-4.66%)	113.55	-5.55	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,421.05(-3.70/-0.26%)	1,421.05	-3.70	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹751.30(-24.20/-3.12%)	751.30	-24.20	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹25,766.00(-378.45/-1.45%)	25,766.00	-378.45	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	5.08	8.64	6.88	7.50	7.94	6.67
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	5.08	8.64	6.88	7.50	7.94	6.67
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.13	0.20	0.14	0.14	0.11	0.14
Total Income	5.21	8.84	7.02	7.64	8.06	6.80
Total Expenditure	5.64	8.92	7.20	7.71	8.58	7.03
PBIDT	-0.43	-0.08	-0.18	-0.07	-0.53	-0.23
Interest	0.02	0.01	0.01	0.03	0.00	0.01
PBDT	-0.46	-0.08	-0.18	-0.10	-0.53	-0.23
Depreciation	0.08	0.09	0.09	0.17	0.06	0.06
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.02	-0.01	0.00	-0.18	0.00	-0.01
Reported Profit After Tax	-0.56	-0.16	-0.27	-0.09	-0.59	-0.29
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.56	-0.16	-0.27	-0.09	-0.59	-0.29

EPS (Unit Curr.)	-0.83	-0.24	-0.39	-0.14	-0.87	-0.43
EPS (Adj) (Unit Curr.)	-0.83	-0.24	-0.39	-0.14	-0.87	-0.43
Calculated EPS (Unit Curr.)	-0.83	-0.24	-0.39	-0.14	-0.87	-0.43
Calculated EPS (Adj) (Unit Curr.)	-0.83	-0.24	-0.39	-0.14	-0.87	-0.43
Calculated EPS (Ann.) (Unit Curr.)	-3.31	-0.95	-1.55	-0.55	-3.46	-1.70
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-3.31	-0.95	-1.55	-0.55	-3.46	-1.70
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	6.83	6.83	6.83	6.83	6.83	6.83
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-8.46	-0.93	-2.62	-0.93	-6.68	-3.45
PBDTM(%)	-9.06	-0.93	-2.62	-1.33	-6.68	-3.45
PATM(%)	-11.02	-1.85	-3.92	-1.20	-7.43	-4.35

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	6.83	6.83	6.83	6.83	6.83	6.83
Reserves Total	3.98	5.23	6.83	6.58	5.99	5.20
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	10.81	12.06	13.66	13.41	12.82	12.03
Secured Loans	0.00	0.00	0.02	0.03	0.19	0.22
Unsecured Loans	0.27	0.03	0.03	0.05	0.00	0.00
Total Debt	0.27	0.03	0.05	0.08	0.19	0.22
Total Liabilities	11.08	12.09	13.71	13.49	13.01	12.25
APPLICATION OF FUNDS :
Gross Block	15.37	15.12	15.12	15.12	15.12	15.08
Less : Accumulated Depreciation	2.59	2.36	2.07	1.72	1.33	0.91
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	12.78	12.76	13.05	13.40	13.79	14.17
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	6.36	4.24	2.63	6.08	5.97	1.29
Sundry Debtors	7.51	3.19	4.27	12.32	11.76	3.79
Cash and Bank	0.69	0.22	0.38	0.15	0.19	0.19
Loans and Advances	0.48	0.65	1.31	1.38	1.28	2.22
Total Current Assets	15.04	8.30	8.59	19.94	19.20	7.50
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	16.73	8.41	7.25	19.10	19.40	8.79
Provisions	0.44	0.44	0.59	0.28	0.26	0.17
Total Current Liabilities	17.16	8.86	7.84	19.38	19.66	8.96
Net Current Assets	-2.12	-0.55	0.75	0.56	-0.46	-1.46
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.06	0.03	0.02	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.14	0.16	0.16	0.00	0.20
Net Deferred Tax	0.06	-0.11	-0.14	-0.16	0.00	-0.20
Total Assets	10.73	12.10	13.67	13.80	13.34	12.52
Contingent Liabilities	0.14	0.13	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.22	0.38	0.15	0.19	0.19
Net Cash from Operating Activities	0.65	-0.18	0.25	0.08	0.06
Net Cash Used In Investing Activities	-0.01	0.01	0.00	0.00	-0.10
Net Cash Used In Financing Activities	-0.16	0.00	-0.02	-0.11	0.04
Net Inc./Dec In Cash And Cash Equivalents	0.48	-0.17	0.23	-0.03	0.00
Cash And Cash Equivalents At End Of The Year	0.69	0.22	0.38	0.15	0.19

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

73.51%

FII Shareholding

0.00%

DII Shareholding

0.06%

Public Shareholding

26.43%

**Promoter pledged shareholding 73.51%

About Phaarmasia Ltd

Phaarmasia Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 28.55 crores. It has reported a sales of Rs. 5.08 crores and a net profit of Rs. -0.56 crores for the quarter ended December 2018. The company management includes , Vinay Ramakant Sapte,Maneesh R Sapte,Y N Bhaskara Rao,Rashmi V Sapte,PRAVIN M. HEGDE,Ajit G Jamkhandikar,Urvashi Bhatia (Phaarmasia Ltd) among others.

Chairman

Registered office

16 Phase III,I D A Jeedimetla,Hyderabad,Telangana,500055

FAX :

Background

Incorporation Year1981

Face Value₹10

Market Lot100

How to buy Phaarmasia shares on nse?

To buy Phaarmasia shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Phaarmasia share price today?

The Phaarmasia shares price on nse is Rs.41.6 today.

What is the market cap of Phaarmasia shares on BSE ?

The company has a market capitalization of Rs.28.55Cr

What is the PE & PB ratio of Phaarmasia shares ?

PE is 0 and PB is 4.65

What is the 52 Week High and Low of Phaarmasia shares?

Phaarmasia stock price high: Rs.46.2 Phaarmasia stock price low: Rs.21.97